Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection

doi:10.3748/wjg.v26.i13.1501

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5964)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

301

WORD

220

HTML

2718

Figures (1-2)

281

Tables (1-4)

199

Sum=3719

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

772

Download

1473

Sum=2245

Apr 7, 2020 (publication date) through Apr 30, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Apr 7, 2020; 26(13): 1501-1512
Published online Apr 7, 2020. doi: 10.3748/wjg.v26.i13.1501

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier survival curves and risk tables for overall survival and recurrence-free survival in the derivation cohort. A: Gamma-glutamyltransferase to lymphocyte ratio > 33.7 was correlated with shorter overall survival; B: Recurrence-free survival in intrahepatic cholangiocarcinoma patients following curative resection. OS: Overall survival; RFS: Recurrence-free survival; GLR: Gamma-glutamyltransferase to lymphocyte ratio; ICC: Intrahepatic cholangiocarcinoma.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan-Meier survival curves and risk tables for overall survival and recurrence-free survival in the validation cohort. A: Gamma-glutamyltransferase to lymphocyte ratio > 33.7 was correlated with shorter overall survival; B: Recurrence-free survival in intrahepatic cholangiocarcinoma patients undergoing curative resection. OS: Overall survival; RFS: Recurrence-free survival; GLR: Gamma-glutamyltransferase to lymphocyte ratio; ICC: Intrahepatic cholangiocarcinoma.

Citation: Wang JJ, Li H, Li JX, Xu L, Wu H, Zeng Y. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection. World J Gastroenterol 2020; 26(13): 1501-1512
URL: https://www.wjgnet.com/1007-9327/full/v26/i13/1501.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i13.1501